Ifosfamide

• 产品号: Bio-0128
• CAS号: 66849-34-1
• 分子式: C7H15Cl2N2O2P
• 分子量: 261.085961

产品别名

• 标题: Ifosfamide
• IUPAC标准名: (2S)-3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2λ^5-oxazaphosphinan-2-one
• IUPAC传统名: (2S)-3-(2-chloroethyl)-2-[(2-chloroethyl)amino]-1,3,2λ^5-oxazaphosphinan-2-one
• 别名: Dexifosfamide

产品登记号

• CAS号: 66849-34-1

产品性质

• 应用领域: Antileukaemic
• 应用领域: Antineoplastic
• 应用领域: Immunosuppressant
• 生物活性机理: Alkylating agent in cancer therapy

参考文献

• Schulten, H.-R., Biomed. Mass Spectrom., 1974, 1, 223, (ms)
• Perales, A. et al., Acta Cryst. B, 1977, 33, 1935, (cryst struct)
• Takamizawa, A. et al., Chem. Pharm. Bull., 1977, 25, 2900, (metab)
• Kinas, R.W. et al., Bull. Acad. Pol. Sci., Ser. Sci. Chim., 1978, 26, 39, (resoln)
• Pankiewicz, K. et al., J.A.C.S., 1979, 101, 7712, (config)
• Ludeman, S.M. et al., J.O.C., 1979, 44, 1163, (synth)
• Wroblewski, A.E. et al., Inorg. Chem., 1980, 19, 3713, (complexes, resoln)
• IARC Monog., 1981, 26, 237; Suppl. 7, 65, (rev, tox)
• Su, C.N. et al., J.A.C.S., 1982, 104, 7343, (cd)
• Misiura, K. et al., J. Med. Chem., 1983, 26, 674, (metab)
• Brade, W.P. et al., Drugs of Today (Barcelona), 1984, 20, 491, (rev)
• Buess, M.L. et al., Org. Magn. Reson., 1984, 22, 67, (nqr)
• Brade, W.P. et al., Cancer Treat. Rep., 1985, 12, 1, (pharmacol, tox, use, rev)
• Anticancer Drug Research. Lectures and Symposia 14th Int. Cancer Congress, Budapest, (ed., Lapis, K. et al), 1986, 9, 127; 133; 139; 155; 171; 177, (rev)
• Kleinrok, Z. et al., Arch. Immunol. Ther. Exp., 1986, 34, 293, (pharmacol, isom)
• Kupfer, A. et al., Lancet, 1990, 335, 1461, (metab)
• Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 483
• Gilard, V. et al., J. Med. Chem., 1999, 42, 2542-2560, (pharmacol, metab)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, IMH000